Evidence map›Paper›PMID 42363835›Full record

ArticleAntimicrobial agents and chemotherapy2026

Antifungal turbinmicin alters functional vesicle cargo.

Robert Zarnowski, Jeniel E Nett, Tim S Bugni, David Andes

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Robert ZarnowskiDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0001-6343-1500
Jeniel E NettDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0001-8587-6244
Tim S BugniSchool of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
David AndesDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-7927-9950

Funding

Vesicle-mediated drug resistance of Candida albicans biofilmR01AI073289 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ANDES, DAVID R, MITCHELL, AARON P · 2008 to 2025
$7.9M
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungiR01AI167883 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI David R Andes, TIMOTHY S BUGNI · 2022 to 2026
$3.8M
NIAID NIH HHS R01 AI073289NIAID NIH HHS R01 AI167883NIH HHS R01 AI073289-16, R01 AI167883
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsExtracellular VesiclesBiofilmsCandida albicansMicrobial Sensitivity TestsAntifungal Agentsantifungalbiofilmmechanismturbinmicin

Identifiers

PMID42363835
PMCPMC13436242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.